Abstract-Experimental studies conducted on animal and human endothelium suggested that higher systolic blood pressure (SBP) variability reduces bioavailability of nitric oxide and increases vascular smooth muscle cell proliferation. These vascular wall changes could stiffen the arterial wall. Using data from the Multiethnic Study of Atherosclerosis, we investigated the association between long-term SBP variability and 10-year percent change in arterial stiffness among 1122 individuals (mean age 57 years, 46% males at baseline) who were not taking antihypertensive medications. Withinindividual standard deviation, variability independent of the mean, and coefficient of variation of SBP across 5 visits were used to capture long-term SBP variability. Carotid arterial stiffness was measured using distensibility coefficient and Young's elastic modulus at baseline and after a mean of 9.5 years of follow-up (visit 5). In a multivariate linear regression model, individuals in the fifth quintile as compared with those in the first quintile of standard deviation, variability independent of the mean, and coefficient of variation of SBP had a 9.8% (95% confidence interval [CI] −17.0%, −2.7%), 6.4% (95% CI −13.2%, 0.4%), and 8.7% (95% CI −15.4%, −1.9%) higher decline in distensibility coefficient and a 27.5% (95% CI 15.8%, 39.3%), 25.8% (95% CI 14.7%, 36.9%), and 27.9% (95% CI 16.8%, 39.1%) higher progression in Young's elastic modulus, respectively, after 10 years of follow-up. Linear trends in the decline of distensibility coefficient and progression of Young's elastic modulus were observed across the quintiles of SBP variability indices. These findings suggest that higher long-term SBP variability may be a risk factor for arterial stiffness progression independent of mean BP. 
levated mean blood pressure (BP) is widely recognized as a major risk factor for target organ damage and all-cause mortality. 1, 2 However, other components of BP, such as shortand long-term variability in BP, have been recently recognized as an important risk factor for development and progression of vascular events. [3] [4] [5] [6] [7] Long-term (visit-to-visit) BP variability was shown to be reproducible over time, 8 more common among individuals with higher cardiovascular risk, 5 and higher among individuals at risk for stroke, 9 indicating that long-term BP variability is a nonrandom phenomenon. In fact, independent of mean BP, long-term variability in BP has been found to be associated with development of coronary heart disease, heart failure, cardiovascular mortality, 10 stroke, 10,11 chronic kidney disease, 6 and cognitive function. 7 However, the mechanism through which higher BP variability causes vascular events is poorly understood. 12, 13 Findings from experimental studies in animals and cultured human endothelium suggested that higher BP variability may cause arterial remodeling, such as vascular smooth muscle cell proliferation and extracellular matrix deposition, and also lead to increased oscillatory shear stress to the vascular endothelium, potentially contributing to increased expression of adhesion molecules and reduced bioavailability of nitric oxide. [12] [13] [14] [15] These structural and functional changes on the vascular wall are common antecedents of arterial stiffness. [16] [17] [18] [19] Thus, the effect of higher long-term BP variability on vascular events may partly occur through a gradual increase in arterial stiffness-which is known to be an independent risk factor for cardiovascular events. 20, 21 The objective of this study was to investigate whether there is an association between long-term systolic BP (SBP) variability and 10-year change in arterial stiffness independent of mean BP level.
Methods

Study Design and Participants
The MESA (Multiethnic Study of Atherosclerosis) is a longitudinal population-based study of risk factors for subclinical and clinical cardiovascular diseases among individuals who were free of clinical cardiovascular disease at baseline. Participants were recruited from 6 centers across the United States (Baltimore, MD; Chicago, IL; Forsyth County, NC; Los Angeles County, CA; Northern Manhattan, NY; and St Paul, MN). The study protocol was approved by the institutional review boards at all 6 field centers, and informed consent was obtained from all participants. Baseline assessment was conducted between Details on design and objectives of MESA can be found in Bild et al. 22 Participants were eligible for the present analysis if (1) they had BP measured on at least 3 out of 5 visits to calculate indices of BP variability, and (2) they were not taking antihypertensive medications at all the visits because BP medication masks pathophysiologic variations in BP. 23 In addition, participants were included in the analysis if they had ultrasonography of the common carotid artery at visits 1 and 5.
Long-Term BP Variability
After participants rested for 5 minutes in a quiet environment, 3 seated brachial BP measurements were taken by a trained and certified research staff in the right arm at an interval of 1 minute using a calibrated Dinamap PRO 100 automated oscillometric device (Critikon, Tampa, FL) 24 with the back and arm supported during each visit. The last 2 measurements were used to calculate averaged BP at each visit, and these averaged values were used to calculate BP variability across the 5 visits (the exposure variable). Long-term SBP variability was quantified using 3 indices: (1) within-individual standard deviation (SD), (2) coefficient of variation (CV; ratio of SD to the mean), and (3) variability independent of mean (VIM). VIM was calculated as the SD divided by the within-individual mean to the power p and multiplied by the average value of SBP in the cohort to the power p. 11, 25 The power p is obtained by fitting a curve of SD against withinindividual mean SBP using the model SD=a times mean p , where p was derived by nonlinear regression analysis as implemented in the SAS PROC NLIN procedure. 11, 25 VIM was shown to correlate highly with other indices of BP variability, 26 while its correlation with mean BP level is almost zero. 11, 27 VIM allows assessing the association of BP variability with outcomes while removing the confounding effect of BP level.
Additional BP phenotypes calculated were within-individual mean SBP by averaging BP values across visits 1 to 5, mean arterial pressure calculated as (SBP+2 diastolic BP)/3 and averaged across the 5 visits, and cumulative exposure to SBP from visit 1 to visit 5, defined as the sum of averaged SBPs between 2 consecutive visits multiplied by the time between these 2 consecutive visits in years as shown in Yano et al. 7 Carotid Artery Stiffness B-mode ultrasound video image of a longitudinal section of the right common carotid artery was taken at visit 1 using a Logiq 700 ultrasound system (General Electric Medical Systems; transducer frequency 13 MHz) by trained and certified sonographers at each MESA site, and images were recorded in a videotape. Video images were digitized at high resolution using a Medical Digital Recording device (PACSGEAR, Pleasanton, CA). Similar recording was made using the same ultrasound and digitizing equipment at visit 5; however, the video images were directly digitized using the Medical Digital Recording settings without use of videotape. The University of Wisconsin-Madison Atherosclerosis Imaging Research Program interpreted the images. The systolic and diastolic diameters of the carotid artery were determined by the largest and smallest diameters during a cardiac cycle. Mean internal diameter at peak systole and mean internal and external diameters at end diastole of carotid artery were calculated from measurements taken from 2 to 3 consecutive cardiac cycles. Intra-and inter-reader reliabilities showed excellent agreement between images read. 28 Two indicators of carotid artery stiffness were calculated. Based on formulas recommended by expert consensus, 29 carotid artery distensibility coefficient (DC) was calculated as (D In addition, demographics (age, sex, and race), anthropometrics (height, weight, and body mass index [BMI]), behavioral factors (physical activity, alcohol intake, and pack-years of cigarette smoked), laboratory data (total cholesterol, high-density lipoprotein cholesterol, serum glucose, creatinine, and glomerular filtration rate [GFR]), and diabetes mellitus status were determined as described in Appendix A in the online-only Data Supplement.
Statistical Analysis
The association between long-term SBP variability indices (SD, VIM, and CV) and 10-year percent change in carotid artery DC and YEM was evaluated using linear regression model while adjusting for potential confounders. To identify potential confounders, we drew a priori directed acyclic graph 30 and applied Pearl's back-door criterion 31 using DAGitty. 32 Potential confounders identified were age, sex, race, smoking, physical activity, alcohol intake, BMI, hypercholesterolemia, diabetes mellitus, GFR, C-reactive protein, menopausal status, and baseline arterial stiffness. In addition, mean arterial pressure and cumulative BP were adjusted when the exposure was SD of SBP and cumulative BP when the exposure was CV of SBP. SD, VIM and CV of SBP across visits 1 to 5 were included in separate regression models. Percent change in DC and YEM were regressed separately on continuous and quintiles of SBP variability indices, and the lowest quintile was used as a reference group. Test of trend across the quintiles was assessed by including indicator of quintiles as a continuous ordinal variable. We assessed interaction of SBP variability indices with age, sex, and race using the most fully adjusted models. In all the analyses, statistical significance was set at P<0.05. Plots of the residuals against the fitted values for all the models were checked to assess assumptions of linearity and homoscedasticity and to check outlier observations in the data. 33 All analyses were performed using Stata 13 (StataCorp. 2013; StataCorp LP, TX).
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Results
Participant Characteristics
In the MESA, there were 2314 participants who had complete data for SBP for at least 3 visits out of the total 5 visits and were not also taking antihypertensive medications at all the visits. Among those, 1122 had ultrasonography imaging of the common carotid artery at both visits 1 and 5 and complete data on adjusted variables. There was no significant difference on most demographic and clinical characteristics between all eligible participants (N=2314) and those who were included in the analysis (N=1122; Table S1 in the online-only Data Supplement). However, the participants included in our analysis were slightly younger (56.8 versus 58.3 years; P<0.001), had lower SBP (113.5 versus 115.4 mm Hg; P<0.001), mean arterial pressure (83.0 versus 84.0 mm Hg; P=0.004), and higher GFR (81.3 versus 80.4 mL/min/1.73 m2; P=0.04), and were less likely to be diabetic (5.3% versus 13.5%; P<0.001) than all eligible participants.
Our participants' age at baseline ranged from 45 to 84 years (mean age 56.8 years), 46.2% were male, 44.2% were White, 17.6% were Black, 16.0% were Chinese, and 22.1% were Hispanic (Table 1) . Compared with individuals with lower SD of SBP (quintile 1), those who had higher SD (quintile 5) tended to be older; to be female; to have higher BMI, SBP, diastolic BP, cumulative SBP. cumulative diastolic BP, mean arterial pressure, total cholesterol, and C-reactive protein; and to have lower high-density lipoprotein and GFR and had higher proportion of female who reached menopause (Table 1) . Similarly, participants with higher VIM of SBP (quintile 5) were older, female, and less likely to exercise and had lower GFR, higher SBP, C-reactive protein, but lower diastolic BP, cumulative diastolic BP, and mean arterial pressure than those with lower VIM (quintile 1; Table 2 ). Similar findings were found across quintiles of CV of SBP (Table S2 ). (Table S3) . Mean (SD) of DC and YEM at visits 1 and 5, as well as the absolute and percent change across the visits, by the quintiles of BP variability indices is given in Tables S3-S5 . Continuous variables were averaged across 5 visits. Individuals identified as diabetic at least once across 5 visits were considered as diabetic. BMI indicates body mass index; BP, blood pressure; CRP, C-reactive protein; GFR, glomerular filtration rate; HDL, high-density lipoprotein; MET, metabolic equivalent of task; Q, quintiles; and SD, standard deviation.
Long-Term SBP Variability and Arterial Stiffness Progression
After adjusting for age, sex, race, study center, pack-years, alcohol intake, physical activity, BMI, heart rate, diabetes mellitus status, total cholesterol, high-density lipoprotein, GFR, C-reactive protein, and menopausal status, DC declined by 13.2% (95% CI −20.7, −5.6) and YEM increased by 31.6% (95% CI 19.6, 43.5) higher among those in the fifth quintile of SD of SBP as compared with those in the first quintile after 10 years of follow-up (Table 3 , Model 1). After adjusting further for cumulative SBP and mean arterial pressure (Table 3 , Model 2), the decline in DC was higher by 8.6% (95% CI −16.6, −0.8) and progression in YEM was higher by 26.8% (95% CI 14.2, 39.4) among those in the fifth as compared with those in the first quintile of SD of SBP. Further adjustment for baseline arterial stiffness showed a 9.8% (95% CI −17.0, −2.7) higher decline in DC and a 27.5% (95% CI 15.8, 39.3) higher increment in YEM comparing individuals in the fifth against the first quintile of SD of SBP variability (Table 3 , Model 3). There was a significant trend in decline of DC (linear trend P=0.049) and progression of YEM (linear trend P<0.001) across the quintiles of SD of SBP in the fully adjusted model.
Mean and SD of BP were shown to correlate moderately.
11,27 Thus, we used VIM of SBP as a second index of BP variability. Figure S1 shows scatter plot of mean SBP against SD and VIM of SBP. In our data, mean SBP correlated moderately with SD (Pearson's correlation =0.49), Continuous variables were averaged across 5 visits. Individuals identified as diabetic at least once across 5 visits were considered as diabetic. BMI indicates body mass index; BP, blood pressure; CRP, C-reactive protein; GFR, glomerular filtration rate; HDL, high-density lipoprotein; MET, metabolic equivalent of task; Q, quintiles; and SD, standard deviation.
while the correlation with VIM was zero (Pearson's correlation =0.002).
There was a 9.0% (95% CI −16.6, −1.5) higher deceleration in DC and a 27.8% (95% CI 15.9, 39.6) higher progression in YEM after 10 years of follow-up among individuals in the fifth quintile of VIM of SBP as compared with those in the first quintile after adjusting for age, sex, race, study center, pack-years, alcohol intake, physical activity, BMI, heart rate, diabetes mellitus status, total cholesterol, high-density lipoprotein, GFR, C-reactive protein, and menopausal status (Table 4 , Model 1). DC decreased 6.4% (95% CI −13.19, 0.43) and YEM increased 25.8% (95% CI 14.7, 36.9) higher after adjusting further for baseline arterial stiffness among individuals in the fifth as compared with those in the first quintile of SBP VIM (Table 4 , Model 2). There was a significant trend of higher progression in YEM (linear trend P<0.001) across the quintiles of VIM of SBP. When CV of SBP was used as the exposure, consistent findings were observed (Table 4 , lower portion). Likewise, a decline in DC and an increment in YEM were observed when SBP variability indices were included as a continuous variable in the models.
Both arterial stiffness and BP variability tend to be higher among the elderly, male, and the minorities, 35-37 and we assessed whether age, sex, and race modify the association of BP variability with arterial stiffness. There was no interaction of sex with indices of SBP variability (interaction P≥0.29 in all). However, when the outcome was percent change in YEM, there was significant interaction of age with SD (interaction P=0.03), VIM (interaction P=0.03), and CV (interaction P=0.003) of SBP, indicting higher progression of arterial stiffness among those aged ≥65 years. There was also a borderline interaction of race with SBP SD (interaction P=0.08 for Blacks and 0.08 for Chinese), VIM (interaction P=0.09 for Blacks), and CV (interaction P=0.06 for Blacks) when the outcome was percent change in DC, suggesting that Blacks had slower progression of arterial stiffness than the other races. Race stratified analysis showed that there was higher decline in DC and progression in YEM among Whites, Hispanic, and Chinese but a nonsignificant change in DC and YEM among Blacks for a unit increase in SBP variability indices ( Figure 1A and 1B) . Similarly, the increase in YEM was higher by ≈2-fold among individuals aged ≥65 years than those aged <65 years for a 1 unit increase in SBP variability indices (Figure 2A ), while there was no appreciable difference on DC ( Figure 2B ).
Discussion
Using 3 indictors of long-term SBP variability and 2 indicators of carotid arterial stiffness, we found that higher longterm SBP variability was associated with greater progression in arterial stiffness over 10 years among individuals who were not taking antihypertensive medications. This association persisted after adjusting for mean BP level, cumulative BP, baseline arterial stiffness, and other confounders. There was significant interaction of race and age with SBP variability. Higher SBP variability was consistently associated with a decline in DC and progression in YEM only among Whites, Hispanic, and Chinese but not among Blacks. The decline in DC and progression in YEM was also higher among individuals aged ≥65 years than those aged <65 years for a similar increase in SBP variability. To our knowledge, there is only one previous study that assessed the association between long-term BP variability and arterial stiffness. 38 In the APAC (Asymptomatic Polyvascular Abnormalities Community) study, Wang et al 38 assessed the variability in SBP across 4 visits (each visit separated by 2 years) using standard deviation and examined its association with brachial-arterial pulse wave velocity at the end of the follow-up year among 3994 Chinese adults. Consistent with our findings, they found that higher SBP variability was associated with higher baPWV (β=6.17 cm/s 95% CI 4.24, 8.12) after adjusting for multiple risk factors. In MESA, baseline arterial stiffness has been found to predict future long-term variability in SBP. 39 It is, therefore, difficult to decipher from Wang et al's 38 study whether higher variability in BP caused stiffer arteries or the vice versa because baseline arterial stiffness was not known and adjusted in their analysis.
Several studies have shown an association between higher short-term SBP variability and stiffer arteries. In a crosssectional study, Schillaci et al 40 found a correlation between SD of daytime (r=0.17) and nighttime (r=0.19) SBP with carotid-femoral pulse wave velocity (efPWV) among 911 untreated and nondiabetic hypertensive patients. Another study by Ichihara et al 41 showed that a 1 SD higher 24-hour ambulatory SBP was associated with an increase in brachial-arterial pulse wave velocity by 38.7 mm/s (95% CI 3.4, 73.9) among 203 newly diagnosed and untreated hypertensive patients after adjusting for confounders. Ozawa et al 42 also found that independent of other risk factors, brachial-arterial pulse wave velocity was lower by 0.23 cm/s (P=0.03) for a SD higher nighttime SBP among 92 hospitalized Japanese hypertensive patients. It was suggested that higher variability in SBP for a prolonged time may result in stiffer artery by promoting proliferation of smooth muscle cells and accelerating the development of atherosclerosis through neurohumoral processes by inducing the expression of several inflammatory factors, such as tumor necrosis factor-α and interleukin-1. 38 Findings from experimental studies on cultured endothelium from animals and humans also suggested that higher BP variability may cause structural changes in the arterial wall, such as extracellular matrix deposition and vascular smooth muscle cells proliferation, and may also increase oscillatory shear stress in the vascular endothelium, potentially promoting expression of adhesion molecules and reducing bioavailability of nitric oxide. [12] [13] [14] [15] These structural and functional changes on the vascular wall are common findings in stiffer arteries. Histological examination of stiffened arteries consistently show inflammatory Figure 1 . Association between systolic blood pressure (BP) variability indices and 10-year percent change in carotid artery DC (A) and YEM (B) by race. Adjusted for age, sex, study center, mean arterial pressure when exposure was SD, DC/YEM, and menopausal status at baseline, and averaged pack-years, alcohol intake, physical activity, BMI, heart rate, total cholesterol, HDL, GFR, C-reactive protein, mean arterial pressure when the exposure was SD of systolic BP, and cumulative exposure to systolic BP across visits 1 to 5 when exposures were SD and CV of systolic BP, and diabetes mellitus status across visits 1 to 5. BMI indicates body mass index; CV, coefficient variation, DC, distensibility coefficient; GFR, glomerular filtration rate; HDL, high-density lipoprotein; SBP, systolic blood pressure; SD, standard deviation; VIM, variability independent of the mean; and YEM, Young's elastic modulus. *P<0.05, †P<0.01, and ‡P<0.001. Adjusted for sex, race/ethnicity, study center, mean arterial pressure when exposure was SD, DC/YEM, and menopausal status at baseline and averaged pack-years, alcohol intake, physical activity, BMI, heart rate, total cholesterol, HDL, GFR, C-reactive protein, mean arterial pressure when exposure was SD of systolic BP, cumulative exposure to systolic BP across visits 1 to 5 when exposures were SD and CV of systolic BP, and diabetes mellitus status across visits 1 to 5. BMI indicates body mass index; BP, blood pressure; CV, coefficient variation, DC, distensibility coefficient; GFR, glomerular filtration rate; HDL, high-density lipoprotein; SBP, systolic blood pressure; SD, standard deviation; VIM, variability independent of the mean; and YEM, Young's elastic modulus. *P<0.05, †P<0.01, and ‡P<0.001.
activity, increased collagen content, broken elastin molecules, hypertrophied smooth muscle layer, and increased matrix metalloproteinases. [16] [17] [18] [19] Arterial stiffness and BP variability may affect each other in a bidirectional manner. Shimbo et al 39 found SBP variability to be higher among individuals with lower baseline aortic distensibility after adjusting for demographic variables, cardiovascular risk factors, mean SBP, and antihypertensive medication. Therefore, unless high BP is controlled and maintained in a steady state, greater BP variability may accelerate the rate of arterial stiffness progression, which in turn may lead to a vicious cycle of more elevated BP variability, causing further increase in arterial stiffness. Furthermore, both higher BP variability and arterial stiffness were shown to be independent risk factors for cardiovascular diseases, 10, 21 and this implies that individuals with higher BP variability and arterial stiffness could be at increased risk for cardiovascular events and mortality. Future studies should investigate the combined adverse effect of high BP variability and increased arterial stiffness on cardiovascular risk.
An interesting finding in our study is that higher SBP variability was associated consistently with progression in arterial stiffness only among Whites, Hispanics, and Chinese but not among Blacks. On the contrary, mean SBP was associated with a greater progression in arterial stiffness in Blacks than in the other races (Table S6 ). This suggests that mean SBP instead of variability in SBP may be an important risk factor for the progression of arterial stiffness among Blacks, while both mean and variation in SBP may be risk factors among other races. Vascular wall changes, such as elastin degradation and excessive deposition of collagen and calcium, are common in the elderly. 43, 44 Thus, the higher progression in arterial stiffness among the elderly as compared with nonelderly for a similar increase in BP variability could be because of the combined stiffening effects of increased age and BP variability on arterial wall.
Some studies found the predictive capacity of longterm BP variability for a clinical outcome diminishing and becoming nonsignificant when BP variability was calculated from 3 or 4 visits, while BP variability calculated from ≥5 visits was a significant predictor. 11, 45 We performed a sensitivity analysis generating long-term SBP variability only from the first 3 or 4 visits of MESA. We found a diminished predictive ability of long-term SBP variability for arterial stiffness progression (Table S7) .
Our study is the first population-based cohort study, to our knowledge, to show a temporal association between higher long-term SBP variability and accelerated progression in arterial stiffness independent of mean BP, baseline arterial stiffness, and other confounders. Our study is also the first to show variation by race and age in the association between SBP variability and progression in arterial stiffness. An additional strength of this study is the inclusion of participants with diverse ethnic backgrounds from the general population, which would increase generalizability of our findings.
However, brachial artery BP was measured only at 5 visits over a mean of 9.5 years of follow-up, and this may not accurately reflect participants' level of SBP variability during that follow-up time. In addition, in the calculation of DC and YEM, brachial artery BP was used as a surrogate for carotid arterial BP. Brachial artery pulse pressure was found to overestimate central pulse pressure, 29, 46 and this may have overestimated arterial stiffness. This error is likely to be nondifferential by SBP variability and may have underestimated the association between SBP variability and arterial stiffness. Furthermore, participants who had arterial stiffness measurement were slightly younger, had slightly lower SBP and mean arterial pressure, had higher GFR, and more likely to be diabetic than all eligible participants (Table S1 ). However, these difference were small and unlikely to cause significant change in the association between SBP variability and arterial stiffness.
Perspectives
Individuals who had higher variability in SBP over 10 years showed greater 10-year progression in arterial stiffness from their baseline value independent of their mean BP, baseline arterial stiffness, and other confounders among Whites, Hispanics, and Chinese but not among Blacks. Our findings suggest that mean SBP instead of variability in SBP may be an important risk factor for the progression of arterial stiffness among Blacks, while mean and variation in SBP may be risk factors among the other races. In addition, the progression in arterial stiffness was higher by ≈2-fold in the elderly compared with the nonelderly for a similar increase in SBP variability. Based on these novel findings, we suggest that higher long-term SBP variability merits consideration as a new risk factor for arterial stiffness progression.
